Sign in

CIK 0001829802 · <br>Emerging growth company

Faeth Therapeutics, Inc.

Sign in to watch
Ticker
FTH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
512-200-2982
Business address
701 TILLERY STREET #12 #1010, AUSTIN, TX, 78702
Former names
Sensei Biotherapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-23 STEPHENSON BRIAN C Chief Financial Officer Purchase +6,836 $24.12 $165K 15,019
2026-06-23 STEPHENSON BRIAN C Chief Financial Officer Purchase +1,969 $24.84 $49K 16,988
2026-06-23 STEPHENSON BRIAN C Chief Financial Officer Purchase +425 $25.91 $11K 17,413
2026-06-22 Parikh Anand Kiran President and CEO Purchase +2,806 $19.76 $55K 764,234
2026-06-22 Parikh Anand Kiran President and CEO Option exercise +45,252 $1.16 $52K 809,486
2026-06-22 Parikh Anand Kiran President and CEO Option exercise +8,213 $1.16 $10K 817,699
2026-06-22 Parikh Anand Kiran President and CEO Option exercise · Employee Stock Option (right to buy) −45,252 91,632
2026-06-22 Parikh Anand Kiran President and CEO Option exercise · Employee Stock Option (right to buy) −8,213 4,107
2026-06-22 STEPHENSON BRIAN C Chief Financial Officer Purchase +1,797 $20.23 $36K 1,797
2026-06-22 STEPHENSON BRIAN C Chief Financial Officer Purchase +1,118 $20.82 $23K 2,915
2026-06-22 STEPHENSON BRIAN C Chief Financial Officer Purchase +1,583 $22.40 $35K 4,498
2026-06-22 STEPHENSON BRIAN C Chief Financial Officer Purchase +3,329 $23.28 $77K 7,827
2026-06-22 STEPHENSON BRIAN C Chief Financial Officer Purchase +356 $23.95 $9K 8,183
2026-06-15 Hahn Stephen M. Director Conversion +44,763 44,763
2026-06-15 Hahn Stephen M. Director Conversion · Series B Preferred Stock −44.76 0
2026-06-15 Parikh Anand Kiran President and CEO Conversion +761,428 761,428
2026-06-15 Parikh Anand Kiran President and CEO Conversion · Series B Preferred Stock −761.43 0
2026-06-12 Hahn Stephen M. Director Grant or award · Stock Option (right to buy) +25,000 25,000
2026-06-12 Ramasastry Saira Director Grant or award · Stock Option (right to buy) +25,000 25,000
2026-06-10 Gerry Christopher President & PEO Grant or award · Stock Option (right to buy) +220,000 220,000

Page 2 of 12 · 238 trades